10 employees
Aptatek is developing a biosensing platform for portable disease management devices.
2008
$4M
from 3 investors over 3 rounds
Aptatek Biosciences raised $4M on March 16, 2022
Investors: National PKU Alliance, IP Group plc and Canterbury Scientific Ltd